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Coronary artery events requiring intervention are associated with depressed cardiac
autonomic function. Whether a 6-week cardiac rehabilitation (CR) differs in effectiveness in
improving exercise capacity (6MWT), cardiorespiratory function (peakVO2), and autonomic
function (HRV) following either cardiac bypass surgery (CABG) or percutaneous coronary
revascularization (PCI) is unknown. The current study therefore compared the change
in 6MWT and peak VO2 to HRV variables following a 6-week CR program and with
patients having either PCI or CABG. Thirty-eight patients, (PCI, n = 22 and CABG, n = 16)
participated in the CR program and results for pre and post 6min walk test (6MWT),
peakVO2, and heart rate variability (HRV) were obtained. Our study has shown that a 6
weeks program following either PCI or CABG improves function. However, the effect on
post-CABG differs to that of post-PCI patients. The change in distance walked (6MWT,
metres) was higher in the CABG (6MWT: 61, p < 0.001) compared to the PCI group
(6MWT: 41, p < 0.001). Maximum exercise capacity (peak VO2, ml/kg.min) also changed
significantly with a greater change in the CABG group (PCI: 0.7, P < 0.001; CABG:
1.0, P < 0.001) but did not reach normal population values. Although an improvement
in HRV parameters was noted for the PCI group, a statistically significant improvement
in HRV was observed only in the CABG group for the following; SDNN (ms) (baseline
vs. post-rehabilitation (median ± IQR): 31.2 ± 25.6 vs. 51.8 ± 23.1, p < 0.01), RMSSD
(19.32 ± 19.9 vs. 42 2.1 ± 34.2, p < 0.01); LF (ms ) (191 ± 216 vs. 631 ± 693, p < 0.01) and
HF (107 ± 201 vs. 449 ± 795.0, p < 0.05). A significant interaction in the PCI group but
not in the CABG group was observed using correlation analysis between the 6MWT and
peak VO2 with HRV parameters indicating that being healthier that is, a better 6MWT and
peak VO2 led to better HRV results but no significant effect of CR in the PCI group. When
the results were investigated for baseline 6MWT and peak VO2 effect using a covariate
analysis, a significant influence of CR on HRV parameters was retained in the CABG group
(p = 0.0072). Our study indicates that a 6-weeks CR program benefits both patient groups
in terms of exercise capacity, cardiorespiratory function and autonomic nervous system
modulation of heart rate, with CABG patients showing the most improvement. HRV can
be a useful additional variable to gauge cardiac function following CR.
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INTRODUCTION
Percutaneous coronary angioplasty intervention (PCI) and coro-
nary artery bypass grafting (CABG) are effective and established
treatments for clinically significant coronary artery disease (CAD)
(Eagle et al., 2004; Bravata et al., 2007). The long-term survival
benefits of cardiac rehabilitation (CR) among patients with CAD
have been documented following several large-scale trials and
meta-analyses with no direct comparisons between cardiac inter-
vention (CABG vs. PCI) or current measures, including the 6-min
walk test and peak oxygen volume (6MWT, peak VO2) (Giannuzzi
et al., 2003; Taylor et al., 2004; Leon et al., 2005; Suaya et al., 2009).
In recent papers there has been some speculation this may be due
to an improvement in cardiac autonomic function (Lucini et al.,
2002; Routledge et al., 2010).
The 6MWT is now used routinely to demonstrate the physical
and physiological benefits of CR following coronary interven-
tion with peak VO2 still used in major metropolitan hospitals
(Fiorina et al., 2007). Recently Soumagne reported improvement
in functional capacity following CR but did not report direct
comparisons between PCI and CABG (Soumagne, 2012).
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Heart rate variability (HRV) is a valid marker of cardiac
autonomic activity and complexity that reflects sympathetic and
parasympathetic balance and overall tone (Mäkikallio et al., 2006;
Jelinek et al., 2010; McLachlan et al., 2010). HRV can be mea-
sured in both time and frequency domains, where global activity
in the time domain is indicated by the standard deviation of
the RR intervals (SDNN) and parasympathetic function by the
root mean square of the standard deviation of the RR intervals
(RMSSD) (TFESC, 1996). Sympathetic output in the frequency
domain is loosely correlated with low frequency (LF) power,
although a parasympathetic component has been noted, while
parasympathetic/vagal output is in part correlated with high fre-
quency (HF) power of the HRV spectrum (Grassi et al., 2009).
The LF/HF ratio is a derived value from the calculated HF and LF
spectral component (Reed et al., 2005; Billman, 2013). Reduced
HRV may be associated with abnormal adaptability of the car-
diac autonomic nervous system to changes in cardiac pathology
and may increase risk of adverse or fatal cardiac events (Kleiger
et al., 1987; Quintana et al., 1997; Weber et al., 1999; Jelinek et al.,
2010).
Parasympathetic indices are reduced in patients within 24 h
after PCI (Tseng et al., 1996; Osterhues et al., 1998; Wennerblom
et al., 2000; Kanadasi et al., 2002). However, this reduction in
parasympathetic function appears to be a transient phenomenon
(Osterhues et al., 1998; Kanadasi et al., 2002; Janowska-Kulin´ska
et al., 2009). In patients with greater than one target-vessel
affected and/or with other comorbidities, HRV remains lower
due to several factors (Tseng et al., 1996; Birand et al., 1998;
Wennerblom et al., 2000; Kanadasi et al., 2002). In advanced heart
failure with low left ventricular ejection fraction autonomic dys-
function may be due to a decrease in muscarinic receptor density,
or changes in neuro-hormonal output leading to a decrease in
parasympathetic output and an increase in sympathetic activity
(Eckberg et al., 1971). In further studies, HRV has been shown
to be independent of ejection fraction, extent of CAD and other
variables, where a decreased HRV is a potent independent pre-
dictor of mortality in the 12 months following elective coronary
angiography in patients without recent myocardial infarction
(Rich et al., 1988). A number of studies have found that CR
can improve both HRV and exercise capacity in patients follow-
ing PCI (Chien et al., 2006; Munk et al., 2009; Baumert et al.,
2011).
In general, outcomes for post-CABG reported in earlier studies
differ to PCI in that impairment of cardiac autonomic regula-
tion assessed by HRV remains suboptimal for several months
or years post CABG and an increased risk of atrial fibrillation
remains present (Demirel et al., 2002; Bauernschmitt et al., 2004;
Cygankiewicz et al., 2004; Wu et al., 2005; Laitio et al., 2006;
Kalisnik et al., 2007). Accordingly, strategies resulting in favor-
able recovery of cardiac autonomic tone as soon as possible
after CABG may be clinically important in these patients. Long-
term outpatient exercise-based CR has been reported to positively
improve exercise capacity and cardiac autonomic function post-
CABG hospital discharge in programs of 2 months duration or
longer (Hirschhorn et al., 2008; Baumert et al., 2011). However,
data evaluating the impact of CR on HRV in outpatients after
CABG are limited (Iellamo et al., 2000; Baumert et al., 2011).
It is uncertain whether short-term CR applied post-CABG dur-
ing an outpatient CR program has a substantial beneficial impact
on HRV and how this compares to current measures of exercise
capacity (6MWT) and cardiorespiratory function (peak VO2). No
study has directly compared the physiological parameters mea-
sured as 6MWT and peak VO2 and cardiac autonomic function
improvements for CABG and PCI patients following a 6-week CR
program.
The current study prospectively compared the impact of a 6
weeks CR program on baseline HRV parameters and exercise
capacity outcomes with patients recovering from both PCI and
CABG in a standardized program.
METHODS
PARTICIPANTS
The project was conducted in accordance with ethics guidelines
and approval by the Sydney Adventist Hospital and Charles Sturt
University Human Ethics Research Committee. All participants
were provided with an information sheet and gave informed
consent.
The participants who agreed to participate in this study
were prospectively and consecutively enrolled between July and
December 2010 and part of the CR program at the Sydney
Adventist Hospital, Wahroonga, NSW, Australia. All patients had
revascularization procedures (either PCI or CABG) within 1
month of enrolment. Patients enrolled into CR were excluded
from the study if the principal diagnosis was of cardiac failure,
valvular surgery, or patients who had a documented myocardial
infarction within 6 months prior to study enrolment. Participants
were also excluded from the analysis if they were unable to com-
plete the 6-week CR program or could not participate in the
designated exercise program.
REHABILITATION PROGRAM
Exercise sessions were performed three times per week for 6 weeks
at 55–70% of peak VO2, measured during the first exercise session
at commencement of the CR program combined with a patient
perceived exertion rating of 11–13 (fairly light to somewhat hard)
on the Borg scale (Borg, 1982). The program included 16 periods
of exercise training and six education sessions on cardiovascular
risk factors, life style modification measures and the pathophysi-
ology of atherosclerosis. The exercise component of the program
was conducted according to the National Heart Foundation of
Australia & Australian Cardiac Rehabilitation Association (NHFA
and ACRA, 2004) guidelines. Each participant was given an indi-
vidualized exercise program consisting of aerobic exercise (cycle
ergometry, treadmill walking, and rowing) that was devised by
an exercise physiologist to ensure the participants could exer-
cise continually throughout the session at the prescribed level
of intensity. Each session consisted of stretching and warm-
up exercise (5–10min), endurance training (15–20min), resis-
tance training (10–15min), or strength training (10–15min)
and cool-down/relaxation exercise (5–10min). Participants were
also advised to complete a home walking program, as recom-
mended by the National Heart Foundation to achieve 30min of
moderate intensity physical activity on most or all days of the
week.
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DATA COLLECTION
The 6-min walk test (6MWT) is a standard measure of func-
tional walking capacity and as such provides insight into the
likely effect of participation on patients’ ability to carry out
activities of daily living (Fiorina et al., 2007). This test consists
of walking up and down an 18m indoor track as many times
as possible within a 6-min period (NHFA and ACRA, 2004;
West et al., 2012). In accordance with the American Thoracic
Society guidelines this test was conducted twice prior to com-
mencing CR, with the better of the two tests recorded as baseline
(Argyropoulos and Harper, 2002). Patients were allowed to rest
if required, and the assessment was ceased if there was angina
pectoris or undue shortness of breath, which would normally
limit activity and/or necessitate the use of coronary vasodilator
therapy. Patients were advised of elapsed time at each minute
of the assessment. No other encouragement was given. The
peak VO2 was collected throughout the 6MWT and calculated
using the American College of Sports Medicine formula (ACSM,
2006).
A 20-min, 3-lead ECG recording (PowerLab 4/30, LabChart
Version 7, Castle Hill, NSW, Australia) was obtained prior and
post CR. Time series variables were analyzed over the 20-min
recording range, whereas frequency domain measures were ana-
lyzed using the accepted 5-min successive interval method to
avoid the influence of non-stationarity (Task Force, 1996). The
time domain variables considered in this study were the mean
RR interval and its standard deviation of the N-N intervals
(SDNN), representing the overall HRV and its root mean square
successive difference (rMSSD), representing the vagal tone. The
frequency-domain variables measured were LF and HF and the
ratio LF/HF, which provide information on vagal and sympathetic
input modulating HRV (Carney et al., 2005).
Other information obtained from patients attending the CR
included medications, blood pressure, smoking, and diabetes sta-
tus. Height and weight were measured, and the body mass index
(BMI) calculated. Waist circumference was measured within an
accuracy of 0.1 cm. Blood pressure was measured with a clinical
zero sphygmomanometer. The average of two measurements was
used to determine blood pressure. A cardiac history questionnaire
was given to all participants to ascertain any other factors thatmay
impact on their exercise capacity and HRV.
DATA ANALYSIS
All the data were analyzed by LabChart version 7
(ADInstruments, Castle Hill, Sydney, Australia). In accor-
dance with the American Thoracic Society guidelines (ATS,
2002), 6MWT results were expressed as an absolute value.
Exercise capacity was expressed as peak VO2 in ml/kg.min.
Statistical analysis was performed using SPSS Version 20
(Copyright IBM Inc.). The Wilcoxon Signed-Ranks Test was used
to compare HRV parameters for the CABG and PCI groups before
and following CR. A student t-test was used to compare the
6MWT and peak VO2 results before and following CR. To assess
the correlation on a nominal scale the Pearson’s correlation test
was used. Covariate analysis to model the influence of 6MWT
and peak VO2 on effectiveness of CR was determined using
Friedman’s test. Differences were considered significant when
p < 0.05. Values were expressed as means and standard devia-
tion for normally distributed data and medians and interquartile
range (IQR) if the data was not normally distributed.
RESULTS
BASELINE VALUES OF PATIENTS
Forty-two patients were consecutively enrolled after successful
cardiac intervention procedures if they agree to the research
and provided informed consent. The PCI group consisted of 25
patients and the CABG group of 17 patients. One patient was
unable to complete the CR program, two missed the follow-up
appointment and one patient was hospitalized during the reha-
bilitation program. No patients experienced angina during the
exercise component of the rehabilitation program. Data from 22
patients in the PCI group and 16 patients in the CABG group were
used for the final analysis.
There were no significant differences in risk profile including
age, blood pressure, smoking, and diabetes, and clinical presen-
tation between the two groups (Table 1). Medication use was
similar between the two groups apart from a significant difference
in the PCI group used angiotensin converting enzyme inhibitors
(ACEI). One patient in the PCI group and two patients in the
CABG group discontinued β-blocker therapy and were excluded
from the analysis.
Table 1 | Patient demographics and clinical history.
PCI (%) CABG (%) P
BASELINE CHARACTERISTICS
Male/female (%) 18 (81.8)/4 (18.2) 13 (81.3)/3 (18.7) NS
Age (years)# 62.5 ± 9.9 64.9 ± 8.8 NS
BMI (kg/m2) 27.5 ± 3.9 27.3 ± 4.6 NS
Waist circumference (cm) 98.1 ± 10.3 97.5 ± 12.0 NS
HISTORY
Past cardiac surgery (%) 1 (4.5) 3 (18.8) NS
Myocardial infarction (%) 11 (50.0) 5 (31.3) NS
Hypertension (treated) (%) 8 (36.4) 10 (62.5) NS
Valvular disease (%) 0 (0.0) 3 (18.8) NS
Arrhythmia (%) AF** 1 (4.5) 3 (18.8) NS
Diabetes (%) 5 (22.7) 1 (6.3) NS
Hyperlipidaemia (%) 17 (77.2) 14 (87.5) NS
Stroke (%) 2 (9.1) 1 (6.3) NS
Kidney problem (%) 1 (4.5) 1 (6.3) NS
Family history (%) 14 (63.6) 15 (93.8) NS
Smoker/ex smokers (%) 1 (4.5)/8 (36.4) 0 (0.0)/3 (18.8) NS
Depression (%) 6 (27.3) 4 (25.0) NS
MEDICATION
β-blockers/Stopped (%) 11 (50.0)/1 (4.5) 8 (50.0)/2 (12.5) NS
Calcium antagonists (%) 0 (0.0) 1 (6.3) NS
Diuretics (%) 2 (9.1) 2 (12.5) NS
Angiotensin converting
enzyme inhibitors
14 (63.6) 4 (25.0) 0.025*
Antiplatelet treatment/
bleeding
22 (100.0)/1 (4.5) 16 (100.0)/0 (0.0) NS
#Mean and standard deviation; *PCI vs. CABG p < 0.05; **Atrial fibrillation.
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CLINICAL VARIABLES
BMI and waist circumference were measured before and after
CR. No significant differences were observed after the 6-week CR
programme (Table 2).
HEART RATE VARIABILITY
Significant increases were seen for SDNN, RMSSD, LF, and HF in
the CABG group following CR compared to baseline (Table 3).
There was no significant change in HRV post CR in the PCI
group for all HRV measures. Significant differences were seen
for the majority of HRV measures for the CABG group when
comparing post CR to baseline levels (Table 3).
Analysis of the difference in the extent of change () between
the CABG and PCI groups for the time and frequency domain
parameters following CR revealed no significant differences in
the HRV parameters. However, CABG patients showed a greater
improvement in all HRV measures.
A significant interaction in the PCI group but not in the CABG
group was observed using covariant analysis between the 6MWT
and peak VO2 withHRV parameters, indicating that being health-
ier that is, better 6MWT and peak VO2, led to better HRV results
but no significant effect of CR in the PCI group. When the results
were investigated for baseline 6MWT and peak VO2 in the CABG
group a significant influence of CR on HRV parameters was
retained in the CABG group (p = 0.0072).
EXERCISE CAPACITY
Clinically significant improvements in exercise capacity were
observed in both PCI and CABG groups following CR as judged
Table 2 | BMI and waist circumference in the CABG and PCI groups.
Variables Baseline 6 weeks P-value
(mean ± SD) (mean ± SD)
PCI_BMI (kg/m2) 27.5 ± 4 27.1 ± 4 0.17
PCI_Waist** (cm) 98.1 ± 10 96.6 ± 9 0.09
CABG_BMI (kg/m2) 27.3 ± 4 27.3 ± 4 0.89
CABG_Waist (cm) 97.5 ± 12 96.5 ± 12 0.12
**waist circumference.
Table 3 | Changes of the HRV indices in PCI and CABG group.
Variables Baseline 6 weeks P-value
(median ± IQR) (median ± IQR)
PCI
SDNN (ms) 49.1±45.3 53.42±35.36 NS
rMSSD 30.17± 46.1 35.68±38.5 NS
LF (ms2) 438±1414 781±1389 NS
HF (ms2) 291±1309 376±821 NS
LF/HF 1.47±0.9 1.87±1.7 NS
CABG
SDNN (ms) 31.19±25.6 51.8±23.1 0.005
rMSSD 19.32±34 61.6±54 0.02
LF (ms2) 191±216 631±639 0.001
HF (ms2) 106±201 449±795 0.02
LF/HF 1.09±1.14 1.06±2.01 NS
by the American Thoracic Society guidelines (2002), which stip-
ulate that an increase of 54m in the 6MWT is the minimum
distance required (Table 4).
Peak VO2 increased significantly in both groups. However, it
remained below international and Australian population norms
that are set between 20 and 35ml/kg.min (see Table 4). CABG
patients improved by 8% and PCI by 1% compared to baseline
following the CR program.
DISCUSSION
Our study is the first to investigate whether there is a difference
in CR outcomes following a 6 week, moderate-intensity exercise
program for patients that have undergone either CABG or PCI
with differing levels of parasympathetic suppression at baseline
(within the first month following intervention but immediately
prior to rehabilitation). Effect of CR on HRV was compared to
the traditional measures of 6MWT and peak VO2. CABG patients
clearly entered the program with lower HRV parameters, partic-
ularly for LF power activity and total HRV, which may be due to
more extensive myocardial or cardiovascular disease and themore
invasive intervention (Santangeli et al., 2008; Lakusic et al., 2009).
CABG intervention has been shown to decrease HRV post-CABG
intervention with HRV parameters not improving past preoper-
ative levels even after 6 months (Kuo et al., 1999). There were
two principal findings: (1) CR significantly improved both HF
power and LF power in the CABG group, which suggests sig-
nificant changes to the extent or functionality of the autonomic
nervous system, (2) CR had a significant impact on the exercise
capacity in both groups. Our study also supports that a short 6-
week CR program as recommended by the Australian guidelines is
sufficient to improve exercise capacity, cardiorespiratory function
regardless of intervention (PCI or CABG) and cardiac autonomic
function in CABG patients (NHFA and ACRA, 2004). Our study
agrees with previous reports that despite patients with diabetes
having a higher risk of adverse cardiac events, adherence to a CR
program can improve functional capacity (Hindman et al., 2005).
Time after intervention is an important component that influ-
ences CR outcomes. We recruited patients between 2 and 4
weeks after intervention and observed that the baseline values
for HRV in the CABG group were much lower than for the PCI
group in agreement with previous studies (Demirel et al., 2002;
Cygankiewicz et al., 2004; Laitio et al., 2006). While there was a
correlation between HRV parameters and 6MWT as well as peak
VO2, this did not explain all the variance, hence indicating HRV is
an independent physiological measure that provides information
Table 4 | 6MWT distance and metabolic variables in both groups at
baseline and after 6 weeks.
Variables Baseline 6 weeks P-value
PCI_6MWT Distance (m) 548.1 ± 62.0* 589.0 ± 78.1 0.001
PCI_Peak VO2 (ml/kg.min) 12.6 ± 1.0 13.3 ± 1.3 0.001
CABG_6MWT Distance(m) 504.3 ± 93.5 565.8 ± 98.8 0.001
CABG_Peak VO2 (ml/kg.min) 11.9 ± 1.6 12.9 ± 1.6 0.001
*Mean and standard deviation.
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on the outcome of CR. HRV may be a more sensitive marker
for effectiveness of improvement in cardiac function. HRV can
be determined from 2-, 5-min, or longer lead II ECG record-
ings (Buchheit et al., 2007). 6MWT did show an improvement
in both groups with only the CABG group meeting the recom-
mended 56 meters cut-off compared to the PCI group. Peak VO2,
demonstrated significant improvement as well for both groups,
but results remained well below published population norms for
our study and age range. This lower than previously reported
outcome in peak VO2 may be due to higher baseline values on
entry to the program especially in the PCI group or possibly due
to patient motivation, home-based compliance, age, gender, and
fitness of the patients. However, even modest improvements are
correlated with better long-term outcomes in cardiorespiratory
function (Swank et al., 2012).
CR has been demonstrated to decrease mortality following
PCI (Goel et al., 2011) and either improved survival or mor-
bidity compared to no CR following CABG in longitudinal
studies (Hedbäck et al., 2001). However, comparative studies
addressing CR effectiveness with respect to the type of car-
diac intervention (PCI vs. CABG) and improvement in HRV
compared to the traditional measures of 6MWT and peak VO2
has not been investigated in the one study design. Our study
indicates that CR following CABG may improve long-term out-
come by reducing the risk of future sudden cardiac death by
increasing parasympathetic tone and therefore HRV (Peng et al.,
1995).
The effectiveness of CR is influenced by type of surgery and
length of rehabilitation program (Eagle et al., 2004). CABG
patients usually have more than one target vessel involved, post-
operative pain, morbidity, and hence their recovery period is
often longer. Patients undergoing PCI, on the other hand, can
begin CR 24–48 h after PCI if there is no evidence of hematoma at
the catheterization site (West et al., 2012). Length of CR may be a
factor in its effectiveness, with many studies reporting an 8-week
period (Austin et al., 2004; Freyssin et al., 2012).
Our study shows in a single center cohort that CR consistently
improved HRV in patients following CABG even when pre CR
values of 6MWT and peak VO2 are considered.
CONCLUSION
This study indicates that the effect of CR is of benefit to patients
with reduced parasympathetic tone prior to the start of CR and
that CR has a greater effect in post-CABG compared to post-
PCI. In addition HRV is independent of 6MWT and peakVO2,
suggesting that HRV is a useful additional measure to employ
for CR.
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